Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical

BEDFORD, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced the divestiture of its Arthrosurface business and the intention to divest of the Parcus Medical business. These decisions are the result of the Company’s ongoing company-wide strategic review.   Management Commentary “The goal […]

[Another] Study Confirms the Benefits of Arthrosurface's OVO® with Inlay Glenoid Shoulder Arthroplasty System

Clinical Study Shows Improved Clinical Outcomes, High Rate of Return to Activity for Patients with Arthrosurface OVO® with Inlay Glenoid Shoulder Arthroplasty System Data published in Journal of Shoulder and Elbow Surgery found excellent range of motion with no reoperations or radiographic loosening. Continue reading for all the details from our press release!

To Top